Stock CELLECTAR BIOSCIENCES INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Cellectar Biosciences Inc Nasdaq

Equities

US15117F2039

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Cellectar Biosciences Inc
14/05 Transcript : Cellectar Biosciences, Inc., Q1 2024 Earnings Call, May 14, 2024
14/05 Cellectar Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Chart calendar Cellectar Biosciences Inc

d76b787ecb6bc2.bWAOxfOgi1n5i8KxJOjR0IGcqmTUn5fqu8EpazSn1wg.NQheqazuuD6KuPLdF5Do4sz93CyWqs2bzrdCP3PPg1whMljyxfezbZbUtQ~d4f8698f04889596984ed9a260485cd6

Upcoming events on Cellectar Biosciences Inc

14/06/2024 07:30 pm Annual General Meeting
12/08/2024 Q2 2024 Earnings Release (Projected)
12/11/2024 Q3 2024 Earnings Release (Projected)
04/03/2025 Q4 2024 Earnings Release (Projected)
12/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Cellectar Biosciences Inc

14/05/2024 06:00 pm Q1 2024 Earnings Call
14/05/2024 04:10 pm Q1 2024 Earnings Release
13/05/2024 10:30 pm Guggenheim Securities Radiopharmaceuticals Day
27/03/2024 06:00 pm Q4 2023 Earnings Call
27/03/2024 04:10 pm Q4 2023 Earnings Release
19/03/2024 09:30 pm Roth Conference
19/03/2024 09:30 pm Roth Conference
15/02/2024 12:30 am Oppenheimer Healthcare Life Sciences Conference
19/01/2024 07:00 pm Investor Meeting - Key Opinion Leader
10/01/2024 03:30 am Biotech Showcase
08/01/2024 06:30 pm Iopofosine I 131 Trial Results Call
08/01/2024 JPMorgan Healthcare Conference
07/12/2023 04:00 pm Targeted Radiopharmaceuticals Summit
02/11/2023 06:00 pm Q3 2023 Earnings Call
02/11/2023 05:00 pm Q3 2023 Earnings Release
25/10/2023 07:30 pm Extraordinary Shareholders Meeting
14/08/2023 06:10 pm Q2 2023 Earnings Release
26/06/2023 Society of Nuclear Medicine and Molecular Imaging Meeting - Abstract No #P1243
23/06/2023 07:30 pm Annual General Meeting
04/05/2023 06:10 pm Q1 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-14,2
-14,3
0.77%		-15,3
-15,8
3.16%		-24,1
-24,5
1.5%		-28,8
-29,7
3.12%		-39,0
-35,4
-9.93%
-51,2

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-14,1
-14,1
0.08%		-15,1
-15,7
3.8%		-24,1
-24,5
1.49%		-28,7
-29,7
3.4%		-38,0
-40,0
4.97%
-46,6

Net income
Million USD		Released
Forecast
Spread 		-14,1
-14,2
0.63%		-15,1
-15,7
3.91%		-24,1
-24,5
1.4%		-28,6
-29,7
3.81%		-38,0
-36,3
-4.5%
-65,4

EPS
USD		Released
Forecast
Spread 		-18,4
-18,9
2.77%		-7,60
-8,20
7.32%		-4,30
-4,43
2.82%		-4,05
-3,31
-22.54%		-3,11
-2,62
-18.59%
-1,89

Announcement Date09/03/2002/03/2121/03/2209/03/2327/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


3,00

EBIT
Million USD		Released
Forecast
Spread 		-6,14
-6,38
3.72%		-7,44
-6,36
-16.95%		-7,82
-7,72
-1.25%		-7,42
-8,35
11.11%		-8,71
-7,64
-13.92%		-8,29
-7,81
-6.19%		-9,41
-8,53
-10.31%		-12,5
-9,47
-32.46%		12,0
-13,3
190.02%
-13,1


-14,5


-16,2


-17,5


-15,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-6,14
-6,15
0.15%		-7,44
-6,24
-19.11%		-7,81
-7,38
-5.91%		-7,28
-8,29
12.19%		-8,58
-8,06
-6.53%		-8,22
-8,37
1.77%		-13,7
-9,12
-50.52%		-7,51
-9,50
20.94%		-21,6
-12,8
-68.45%
-13,1


-13,4


-14,0







Net income
Million USD		Released
Forecast
Spread 		-6,14
-6,38
3.72%		-7,44
-6,36
-16.94%		-7,81
-7,66
-1.92%		-7,22
-8,35
13.54%		-8,58
-7,64
-12.34%		-8,22
-7,80
-5.47%		-13,7
-8,53
-60.92%		-7,45
-9,24
19.38%		-21,6
-13,3
-61.9%
-13,1


-14,5


-16,2


-17,5


-15,4

EPS
USD		Released
Forecast
Spread 		-1,00
-1,00
0%		-1,22
-1,04
-17.87%		-1,28
-1,26
-1.86%		-0,55
-1,08
48.84%		-0,76
-0,87
12.39%		-0,73
-0,67
-9.77%		-1,21
-0,45
-171.91%		-0,40
-0,53
24.53%		-0,74
-0,56
-31.36%
-0,37


-0,37


-0,41


-0,50


-0,40

Announcement Date10/05/2205/08/2203/11/2209/03/2304/05/2314/08/2313/11/2327/03/2414/05/24-----

Upcoming sector events for Cellectar Biosciences Inc

20/05/2024 TARO PHARMACEUTICAL INDUSTRIES LTD.: Q4 2024 Earnings Release
22/05/2024 CSPC PHARMACEUTICAL GROUP LTD.: Q1 2024 Earnings Release (Projected)
22/05/2024 GLAND PHARMA LIMITED: Q4 2024 Earnings Release
23/05/2024 ERIS LIFESCIENCES LIMITED: Q4 2024 Earnings Release (Projected)
24/05/2024 TORRENT PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
27/05/2024 NATCO PHARMA LIMITED: Q4 2024 Earnings Release
27/05/2024 DIVI'S LABORATORIES LIMITED: Q4 2024 Earnings Release (Projected)
28/05/2024 DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release
29/05/2024 IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release
29/05/2024 MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release (Projected)
More events

Past sector events for Cellectar Biosciences Inc

Today J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
Today GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
15/05/2024 07:35 pm MANKIND PHARMA LIMITED: Q4 2024 Earnings Release
15/05/2024 11:00 am DERMAPHARM HOLDING SE: Q1 2024 Earnings Release
15/05/2024 05:10 pm CRESCO LABS INC.: Q1 2024 Earnings Release
15/05/2024 12:33 pm GRANULES INDIA LIMITED: Q4 2024 Earnings Release
15/05/2024 EISAI CO., LTD.: Q4 2023 Earnings Release
15/05/2024 03:13 am LIQUIDIA CORPORATION: Q1 2024 Earnings Release
14/05/2024 02:22 pm BORA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release
14/05/2024 11:00 am BAYER AG: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. CLRB Stock
  4. Stock
  5. Calendar Cellectar Biosciences Inc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW